Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12617001532392
ACTRN12617001532392
Not yet recruiting
未知

To determine whether medical management including maintenance dialysis versus medical treatment alone reduces mortality and morbidity in highly co-morbid patients aged over 75 years with stage 5 chronic kidney disease,

The George Institute for Global Health0 sites150 target enrollmentNovember 6, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEnd Stage Kidney diseaseRenal and Urogenital - Kidney disease

Overview

Phase
未知
Intervention
Not specified
Conditions
End Stage Kidney disease
Sponsor
The George Institute for Global Health
Enrollment
150
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Aged greater than or equal to 75 years
  • •2\.With advanced chronic kidney disease, defined as having an eGFR of less than or equal to 12 ml/min/1\.73m2
  • •3\.Is expected by their treating physician to meet clinical criteria for entry to a maintenance dialysis program within the next 24 months.
  • •4\.Has satisfied the treating unit’s policies relating to education regarding end stage kidney disease treatment options
  • •5\.The treating physician caring for the participant has equipoise about the balance of risk and benefit for the participant should they enter either treatment arm of the study.

Exclusion Criteria

  • •1\.Treating physician considers it unlikely that the participant will adhere to allocated study treatment
  • •2\.Participant unable to understand the implications of both of the study treatment arms for their future care
  • •3\. The treating physician expects that the participant will not survive 3 months beyond study randomisation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
STUDY ON SIDDHA MEDICINE TO MANAGE AND TREAT MENTAL AND BEHAVIOURAL PROBLEMS IN CHILDREHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
CTRI/2019/12/022286ational Institute of Siddha
Completed
Phase 3
thaamani Nei(Internal) and Nellikkai thylam (External) in the management of Mantha Sanni (Autism spectrum disorder)
CTRI/2021/08/035524ational Institute of Siddha
Recruiting
Not Applicable
Clinical Observation, Management, and Function Of low back pain Relief Therapies (COMFORT)iberal prescribing of opioids by GPLiberal prescribing of opioids by GPPublic Health - Health service research
ACTRN12622001505796The University of Sydney410
Not yet recruiting
Not Applicable
The role of Rasayana therapy in management of chemotherapy induced side effects
CTRI/2021/05/033866Rasayu Cancer Clinic Pune
Completed
Not Applicable
Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 RegisterCOVID-19 induced ARDSIntensive care unit treatment (participation in DIVI ECMO COVID Register) ECMO therapy during intensive careJ80U07.1U99.0J12.8Z11Z20.8Adult respiratory distress syndromeCOVID-19, virus identifiedOther viral pneumoniaSpecial screening examination for infectious and parasitic diseasesContact with and exposure to other communicable diseases
DRKS00022964Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)1,300